1 唐奕,龚斐,罗克莉,等.200例长方案卵胞浆内单精子注射周期注射人绒毛膜促性腺激素时机的分析.生殖医学杂志,2013,22:280-284. 2 Wirleitner B,Okhowat J,Vištejnová L,et al.Relationship between follicular volume and oocyte competence,blastocyst development and live-birth rate:optimal follicle size for oocyte retrieval.Ultrasound Obstet Gynecol,2018,51:118-125. 3 Abbara A,Vuong LN,Ho V N A,et al.Follicle Size on Day of Trigger Most Likely to Yield a Mature Oocyte.Front Endocrinol,2018,9:1-11. 4 Lin H,Li Y,Wang W,et al.Role of the proportion of dominant follicles in patientswith PCOS undergoing in vitro fertilization-embryo transfer.中华医学杂志(英文版),2019,132:1448-1453. 5 谢燕秋,李松,林海燕,等.HCG日直径大于20mm的卵泡比例对IVF/ICSI助孕结局的影响.生殖医学杂志,2018,27:345-349. 6 李轶,李瑞岐,区颂邦,等.成熟卵泡比例与HCG注射时机的选择及对卵子发育潜能的影响.中山大学学报(医学科学版),2014,35:552-558. 7 张少娣,路锦,耿嘉瑄,等.hCG注射日雌二醇(E2)增幅及每成熟卵泡E2水平对控制性促排卵hCG扳机的影响.生殖与避孕,2014,34:415-420. 8 Martinez F,Rodriguez I,Devesa M,et al.Should progesterone on the human chorionic gonadotropin day still be measured?.Fertil Steril,2016,105:86-92. 9 Wu Z,Dong Y,Ma Y,et al.Progesterone elevation on the day ofhCG trigger has detrimental effect on live birth rate in low and intermediate ovarian responders,but not in high responders.Sci Rep-UK,2019,9:1-10. 10 丛日敏.超促排卵周期中高激素水平对种植窗的影响.中国实用医药,2018,13:64-65. 11 Farhi J,Orvieto R,Gavish O,et al.The association between follicular size on human chorionic gonadotropin day and pregnancy rate in clomiphene citrate treated polycystic ovary syndrome patients.Gynecol Endocrinol,2010,26:546-548. 12 Shalom-Paz E,Marzal A,Wiser A,et al.Does optimal follicular size in IUI cycles vary between clomiphene citrate and gonadotrophins treatments? Gynecol Endocrinol,2013,30:107-110. 13 Seckin B,Pekcan M K,Bostanci E I,et al.Comparison of pregnancy rates in PCOS patients undergoing clomiphene citrate and IUI treatment with different leading follicular sizes.Arch Gynecol Obstet,2016,293:901-906. 14 Palatnik A,Strawn E,Szabo A,et al.What is the optimal follicular size before triggering ovulation in intrauterine insemination cycles with clomiphene citrate or letrozole? An analysis of 988 cycles.Fertil Steril,2012,97:1089-1094. 15 唐淮云.体外受精—胚胎移植周期微刺激方案中HCG注射日血清LH水平对治疗结局的影响.苏州大学,2013. 16 Gilliam ML.Gonadotrophin-releasing hormone antagonists for assisted reproductive technology.Obstet Gynecol,2011,118:706-707. 17 Boostanfar R,Shapiro B,Levy M,et al.Large,comparative,randomized double-blind trial confirming noninferiority of pregnancy rates for corifollitropin alfa compared with recombinant follicle-stimulating hormone in a gonadotropin-releasing hormone antagonist controlled ovarian stimulation protocol in older patients undergoing in vitro fertilization.Fertil Steril,2015,104:94-103. 18 Lawrenz B,Beligotti F,Engelmann N,et al.Impact of gonadotropin type on progesterone elevation during ovarian stimulation in GnRH antagonist cycles.Hum Reprod,2016,31:2554-2560. 19 Aghahosseini M,Aleyasin A,Chegini V,et al.Low-dose hCG as trigger day and 35 hr later have different ovarian hyperstimulation syndrome occurrence in females undergoing In vitro fertilization:An RCT.Int J Reprod Biomed,2017,15:735-740. 20 Yang W,Hwang Y,Lin C,et al.Embryonic early-cleavage rate is decreased with aging in GnRH agonist but not inantagonist protocols.J Assist Reprod Gen,2015,32:789-795. 21 Hu X,Luo Y,Huang K,et al.New perspectives on criteria for the determination of HCG trigger timing in GnRH antagonist cycles.Medicine,2016,95:e3691. 22 Efstratios M,Kolibianakis MD.,Ph D,et al.Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists.Fertil Steril,2004,82:102-107. 23 Samara N,Reis D,Danielli Miller N,et al.What are the best predictors for successful GnRH antagonist protocol in in vitro fertilization (IVF) treatment.Gynecol Endocrinol,2015,31:877-879. 24 Nogueira D,Friedler S,Schachter M,et al.Oocyte maturity and preimplantation development in relation to follicle diameter in gonadotropin-releasing hormone agonist or antagonist treatments.Fertil Steril,2006,85:578-583. 25 Van Vaerenbergh I,Fatemi H M,Blockeel C,et al.Progesterone rise on HCG day in GnRH antagonist/rFSH stimulated cycles affects endometrial gene expression.Reprod Biomed Online,2011,22:263-271. 26 Mascarenhas M,Shashikant Kamath M,Chandy A,et al.Progesterone/estradiol ratio as a predictor in the ART cycles with premature progesterone elevation on the day of hCG trigger.J Reprod Infertil,2015,16:155-16. 27 宁艳春,刘秀荣,韩宝生,等.183 例自然周期 IVF-ET 临床分析.中国妇幼保健,2013,28:3826-3827. 28 Paulson R J,Chung K,Quaas A M,et al.Low-dose human chorionic gonadotropin alone can complete follicle maturity:successful application to modified natural cycle in vitro fertilization.Fertil Steril,2016,105:1228-1231. 29 Litwicka K,Mencacci C,Arrivi C,et al.HCG administration after endogenous LH rise negatively influences pregnancy rate in modified natural cycle for frozen-thawed euploid blastocyst transfer:a pilot study.J Assist Reprod Gen,2018,35:449-455. 30 奚倩雯,匡延平.高孕激素状态下促排卵—一种新的促排卵方案.中华生殖与避孕杂志,2018,38:147-151. 31 Huang PX,TangML,Qin AP.Progestin-primed ovarian stimulation is a feasible method for poor ovarian responders undergoing in IVF/ICSI compared to a GnRH antagonist protocol:A retrospective study.J Gynecol Obstet Hum Reprod,2019,48:99-102. 32 刘格琳,王芳,柳胜贤.卵巢低反应患者高孕激素状态下促排卵的应用意义评定.泰山医学院学报,2017,38:1168-1169. 33 Yu S,Long H,Chang H Y,et al.New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF:a randomized controlled trial including 516 first IVF/ICSI cycles.Hum Reprod,2018,33:229-237. 34 禹果,项云改,李艳,等.高效孕激素下超促排卵和微刺激方案在卵巢功能减退患者中应用效果分析.中国实用妇科与产科杂志,2017,33:502-506. 35 Huang C,Chen G,Shieh M,et al.An extremely patient-friendly and efficient stimulation protocol for assisted reproductive technology in normal and high responders.Repod Biol Endocrin,2018,16:1-7. 36 Guo Y,Chen P,Li T,et al.Different progestin-primed ovarian stimulation protocols in infertile women undergoing in vitro fertilization/intracytoplasmic sperm injection:an analysis of 1188 cycles.Arch Gynecol Obstet,2019,299:1201-1212.
